Strict quality control of medicines is a cornerstone of modern healthcare all around the world. Much of these analyses are performed by determining identity and concentrations of active ingredients, impurities, raw materials, counterions and other excipients in pharmaceutical formulations.
Diduco contributes by providing reliable products and developing new methods following the ICH guidelines, thus complying with the requirements in pharmacopoeia monographs including USP and Ph. Eur., that are enforced by FDA and other regulative bodies. Diduco support initiatives to develop modernised and more appropriate monograph methods using modern tools and instruments and have for example developed and published a new validated assay according to AQbD (analytical quality by design) principles for the antiviral medicine foscarnet using suppressed ion chromatography.
Get in contact
I’ll be happy to answer any questions you might have regarding our products and services.
Tobias Jonsson
CEO, PhD in chemistry
Mobile: +46 705783490
E-mail: tobias@diduco.com